Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study

Summary

The investigators will determine the feasibility, safety and efficacy of intravenous sodium bicarbonate in reducing progression to overt acute renal failure in patients with the systemic inflammatory response syndrome, and low urine output or early acute renal impairment as defined by serum neutrophil gelatinase-associated lipocalin (NGAL).

Timeline

Start

2010-02

Primary completion

2012-09

Completion

2012-09

Drugs

Indications